Effects of the Putatively Oncogenic Protein Kinase Cα D294G Mutation on Enzymatic Activity and Cell Growth and its Occurrence in Human Thyroid Neoplasias

R. Assert; R. Kötter; U. Schiemann; P. Goretzki; A. F. H. Pfeiffer

doi:10.1055/s-2002-33259

Hormone and Metabolic Research, Table of Contents

Horm Metab Res 2002; 34(6): 311-317
DOI: 10.1055/s-2002-33259

Original Clinical

Effects of the Putatively Oncogenic Protein Kinase Cα D294G Mutation on Enzymatic Activity and Cell Growth and its Occurrence in Human Thyroid Neoplasias

R. Assert ¹ , R. Kötter ² , U. Schiemann ³ , P. Goretzki ⁴ , A. F. H. Pfeiffer ¹

¹ German Institute of Human Nutrition, Potsdam-Rehbrücke, Germany and Department of Endocrinology Diabetes and Nutrition, University Hospital Benjamin Franklin, Free University of Berlin, Germany
² Dept. of Internal Medicine and Policlinic Bergmannsheil, Bochum, Germany
³ Klinik Innenstadt, Medical Policlinic of Ludwig Maximilians University, München, Germany
⁴ Dept. of Surgery and Policlinic, Heinrich Heine University, Düsseldorf, Germany

Abstract

A point mutation of protein kinase Cα (PKCα) has been described in pituitary adenomas and in follicular adenomas and thyroid carcinomas. The mutation results in an exchange of aspartic acid into a glycine of the amino acid 294 of PKCα, which is located adjacent to the Ca²⁺-binding hinge region and has been proposed as an activation inhibitor. To investigate its biochemical sequelae, we constructed the mutated enzyme and expressed it in human embryonic kidney cells (HEK). The K_M of the purified enzyme for Ca²⁺ and its K_M for the substrate MBP_{4 - 14} was not altered by the mutation. Translocation of PKCα to HEK cell membranes upon activation was not changed and the mutant potently inhibited cell proliferation upon 5-fold stable overexpression in HEK cells. Thus, loss of function in mutated PKCα was excluded. A screen for the mutation using a restriction assay with a sensitivity of at least 8 % for the mutated DNA did not show any mutation in 11 carcinoma and 13 adenomatous thyroid samples. We conclude that the A294G mutation of PKCα does not detectably affect its biochemical properties in vitro or in vivo, and is at least rare in thyroid neoplasias, in Germany.

Keywords

Purification - Enzyme Activity - Mutagenesis - Cell Growth - HEK Cells

Full Text

References

1 Parker P J, Coussens L, Totty N, Rhee L, Young S, Chen E, Waterfield M D, Francke U, Ullrich A. The complete primary structure of protein kinase-C the major phorbol ester receptor. Science. 1986; 233 853-858
2 Kikkawa U, Ogita K, Ono Y, Asaoka Y, Shearman M S, Fujii T, Ase K, Sekiguchi K, Igarashi K, Nishizuka Y. The common structure and activities of four subspecies of rat brain protein kinase C family. FEBS Letters. 1987; 223 212-216
3 Rubin A L, Rubin H. Selective nature of phorbol 12-myristate 13-acetate-induced neoplastic transformation in NIH 3T3 cells. Proc Natl Acad Sci. U.S.A.. 1994; 91 2320-2323
4 Duchemin A M, Enyeart J A, Biagi B A, Foster D N, Mlinar B, Enyeart J J. Ca²⁺ channel modulation and kinase-C activation in a pituitary cell line: induction of immediate early genes and inhibition of proliferation. Mol Endocrinol. 1992; 6 563-571
5 Dicker P, Rozengurt E. Stimulation of DNA synthesis by tumour promoter and pure mitogenic factors. Nature. 1978; 276 723-726
6 Alvaro V, Prevostel C, Joubert D, Slosberg E, Weinstein B I. Ectopic expression of a mutant form of PKC alpha originally found in human tumors: aberrant subcellular translocation and effects on growth control. Oncogene. 1997; 14 677-685
7 Prevostel C, Alvaro V, de Bosvilliers F, Martin A, Jaffiol C, Joubert D. The natural protein kinase C alpha mutant is present in human thyroid neoplasms. Oncogene. 1995; 11 669-674
8 Alvaro V, Touraine P, Raisman V R, Bai-Grenier F, Birman P, Joubert D. Protein kinase C activity and expression in normal and adenomatous human pituitaries. Int J Cancer. 1992; 50 724-730
9 Alvaro V, Levy L, Dubray C, Roche A, Peillon F, Querat B, Joubert D. Invasive pituitary tumors express a point mutated alpha-protein kinase C. Journal of Clinical Endocrinology and Metabolism. 1993; 77 1125-1129
10 Schiemann U, Assert R, Moskopp D, Gellner R, Hengst K, Gullotta F, Domschke W, Pfeiffer A. Analysis of a protein kinase C-alpha mutation in human pituitary tumours. J Endocrinol. 1997; 153 131-137
11 Janjic D, Wollheim C B. Islet cell metabolism is reflected by the MTT (tetrazolium) colorimetric assay. Diabetologia. 1992; 35 482-485
12 Assert R, Schatz H, Pfeiffer A. Upregulation of PKC delta- and downregulation of PKC alpha-mRNA and protein by phorbol ester in human T84 cells. FEBS Letters. 1996; 388 195-199
13 Burns D J, Bloomenthal J, Lee M H, Bell R M. Expression of the alpha, beta II, and gamma protein kinase C isozymes in the baculovirus-insect cell expression system. Purification and characterization of the individual isoforms. J biol Chem. 1990; 265 12 044-12 051
14 Yasuda I, Kishimoto A, Tanaka S, Tominaga M, Sakurai A, Nishizuka Y. A synthetic peptide substrate for selective assay of protein kinase C. Biochem Biophys Res Commun. 1990; 166 1220-1227
15 Ron D, Chen C H, Caldwell J, Jamieson L, Orr E, Mochly-Rosen D. Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins. Proc Natl Acad Sci U.S.A.. 1994; 91 839-843
16 Ron D, Mochly-Rosen D. Agonists and antagonists of protein kinase C function, derived from its binding proteins. J Biol Chem. 1994; 269 21 395-21 398
17 Frey M R, Saxon M L, Zhao X, Rollins A, Evans S S, Black J D. Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21waf1/cip1 and p27kip1 and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells. J Biol Chem. 1997; 272 (4) 9424-9435
18 Brooks G, Goss M W, East J A, Hart I R. Growth of melanocytic cells is associated with down-regulation of protein kinase C alpha, delta, and epsilon isoforms. Possible role of diacylglycerol. J Biol Chem. 1993; 268 23 868-23 875
19 Matsui M S, Chew S L, DeLeo V A. Protein kinase C in normal human epidermal keratinocytes during proliferation and calcium-induced differentiation. Journal of Investigational Dermatology. 1992; 99 565-571
20 Rosenbaum S E, Niles R M. Regulation of protein kinase C gene expression by retinoic acid in B16 mouse melanoma cells. Arch Biochem Biophys. 1992; 294 123-129
21 Edashige K, Sato E F, Akimaru K, Kasai M, Utsumi K. Differentiation of HL-60 cells by phorbol ester is correlated with up-regulation of protein kinase C-alpha. Arch Biochem Biophys. 1992; 299 200-205
22 Ron D, Luo J, Mochly-Rosen D. C2 region-derived peptides inhibit translocation and function of a protein kinase C in vivo. J Biol Chem. 1995; 270, No. 41 24 180-24 187
23 Duchemin A M, Enyeart J A, Biagi B A, Foster D N, Mlinar B, Enyeart J J. Ca²⁺ channel modulation and kinase-C activation in a pituitary cell line: induction of immediate early genes and inhibition of proliferation. Molecular Endocrinology. 1992; 6 563-571
24 Isakov N, Galron D, Mustelin T, Pettit G R, Altman A. Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C. J Immunol. 1993; 150 1195-1204
25 Finkerzeller G, Marm D, Hug H. Inducible overexpression of human PKC-alpha in NIH 3T3 fibroblasts results in growth abnormalities. Cell Signal. 1992; 4 163-177
26 Benzil D L, Finkelstein S D, Epstein M H, Finch P W. Expression pattern of alpha-protein kinase C in human astrocytomas indicates a role in malignant progression. Cancer Research. 1992; 52 2951-2956
27 Perletti G P, Smeraldi C, Porro D, Piccinini F. Involvement of the alpha isoenzyme of protein kinase C in the growth inhibition induced by phorbol esters in MH1C1 hepatoma cells. Biochem Biophys Res Commun. 1994; 205 1589-1594
28 Seger R, Krebs E G. The MAPK signaling cascade. FASEB Journal. 1995; 9 726-735
29 Prevostel C, Martin A, Alvaro V, Jaffiol C, Joubert D. Protein kinase C alpha and tumorigenesis of the endocrine tissue. Horm Res. 1997; 47 140-146
30 Kolch W K, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marm D, Rapp U R. Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature. 1993; 364 249-252

A. F. H. Pfeiffer, M.D.

Deutsches Institut für Ernährungsforschung

Arthur-Scheunert-Allee 114-116 · 14588 Bergholz-Rehbrücke · Germany ·

Phone: + 49 (33 200) 88 770

Fax: + 49 (33 200) 88 777

Email: afhp@mail.dife.de